Think MPS
Early clues — coarsening facial features, joint stiffness, hernias, recurrent ear and respiratory infections, or subtle skeletal changes — are often treated as isolated childhood issues rather than signs of a single underlying condition. Recognizing this pattern early, before multi-system involvement sets in, is where pediatricians can make a difference.
Act Early
Because these signs mimic more common presentations, diagnosis is often delayed until several systems are visibly affected. Once MPS is suspected, urinary GAG screening, enzyme assay, and genetic testing can confirm the diagnosis and subtype relatively quickly. Acting early means testing on suspicion rather than waiting for the clinical picture to complete itself.
Transform Lives
For several MPS types, enzyme replacement therapy is the established treatment, and hematopoietic stem cell transplantation is indicated in severe MPS I, with outcomes consistently better the earlier treatment begins. Coordinated care across cardiology, orthopedics, ENT, ophthalmology, and neurology, alongside sustained family support, addresses the condition's wider effects.
